136 related articles for article (PubMed ID: 9267006)
1. Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments.
Koletzki D; Zankl A; Gelderblom HR; Meisel H; Dislers A; Borisova G; Pumpens P; Krüger DH; Ulrich R
J Gen Virol; 1997 Aug; 78 ( Pt 8)():2049-53. PubMed ID: 9267006
[TBL] [Abstract][Full Text] [Related]
2. New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge.
Ulrich R; Koletzki D; Lachmann S; Lundkvist A; Zankl A; Kazaks A; Kurth A; Gelderblom HR; Borisova G; Meisel H; Krüger DH
J Biotechnol; 1999 Aug; 73(2-3):141-53. PubMed ID: 10486924
[TBL] [Abstract][Full Text] [Related]
3. Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.
Kazaks A; Lachmann S; Koletzki D; Petrovskis I; Dislers A; Ose V; Skrastina D; Gelderblom HR; Lundkvist A; Meisel H; Borisova G; Krüger DH; Pumpens P; Ulrich R
Intervirology; 2002; 45(4-6):340-9. PubMed ID: 12602354
[TBL] [Abstract][Full Text] [Related]
4. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
[TBL] [Abstract][Full Text] [Related]
5. HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein.
Koletzki D; Biel SS; Meisel H; Nugel E; Gelderblom HR; Krüger DH; Ulrich R
Biol Chem; 1999 Mar; 380(3):325-33. PubMed ID: 10223335
[TBL] [Abstract][Full Text] [Related]
6. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
8. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
Schödel F; Peterson D; Hughes J; Milich DR
Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
[TBL] [Abstract][Full Text] [Related]
9. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three different recombinant hepatitis B virus core particles expressed in Escherichia coli.
Maassen A; Rehfeldt A; Kiessig S; Ladhoff A; Höhne WE; Meisel H
Arch Virol; 1994; 135(1-2):131-42. PubMed ID: 8198438
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus core antigen: enhancement of its production in Escherichia coli, and interaction of the core particles with the viral surface antigen.
Tan WS; Dyson MR; Murray K
Biol Chem; 2003 Mar; 384(3):363-71. PubMed ID: 12715887
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen.
Ulrich R; Borisova GP; Gren E; Berzin I; Pumpen P; Eckert R; Ose V; Siakkou H; Gren EJ; von Baehr R
Arch Virol; 1992; 126(1-4):321-8. PubMed ID: 1381912
[TBL] [Abstract][Full Text] [Related]
13. Erratum to "characterization and diagnostic potential of hepatitis B virus nucleocapsid expressed in E. coli and P. pastoris".
Watelet B; Quibriac M; Rolland D; Gervasi G; Gauthier M; Jolivet M; Letourneur O
J Virol Methods; 2002 Apr; 102(1-2):175-90. PubMed ID: 11879706
[TBL] [Abstract][Full Text] [Related]
14. Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles.
Koletzki D; Lundkvist A; Sjölander KB; Gelderblom HR; Niedrig M; Meisel H; Krüger DH; Ulrich R
Virology; 2000 Oct; 276(2):364-75. PubMed ID: 11040127
[TBL] [Abstract][Full Text] [Related]
15. Core particles of hepatitis B virus as carrier for foreign epitopes.
Ulrich R; Nassal M; Meisel H; Krüger DH
Adv Virus Res; 1998; 50():141-82. PubMed ID: 9520999
[TBL] [Abstract][Full Text] [Related]
16. The hepatitis nucleocapsid as a vaccine carrier moiety.
Milich DR; Peterson DL; Zheng J; Hughes JL; Wirtz R; Schödel F
Ann N Y Acad Sci; 1995 May; 754():187-201. PubMed ID: 7542855
[TBL] [Abstract][Full Text] [Related]
17. Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly.
Schödel F; Peterson D; Zheng J; Jones JE; Hughes JL; Milich DR
J Biol Chem; 1993 Jan; 268(2):1332-7. PubMed ID: 8419335
[TBL] [Abstract][Full Text] [Related]
18. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
[TBL] [Abstract][Full Text] [Related]
20. Multiple optimizations of recombinant plasmid for improving expression of Hepatitis B core antigen in Escherichia coli.
Zhang Y; Guo M; Zhang X; Zhang N; Zhu P; Wang H
Protein Expr Purif; 2022 Oct; 198():106127. PubMed ID: 35660658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]